A recent study done on rats show that the herb Phyllanthus emblica extract is a very promising agent to prevent Alzheimer’s disease (AD). This is not surprising as the herb modulates inflammation, a key factor in the development of Alzheimer’s disease. This makes it a herb suitable for long-term consumption without much side effects compared to other anti-inflammatory agents such as omega 3 oil and turmeric.
Although the study was done on rats, the mechanism of action found can be a strong indication for humans ( as in many other studies). In addition, previous human studies have found the herb extract found in Phytolec ( a product with the main ingredient as patent amla extract) significantly reduces hs-CRP, the standard inflammation marker. CRP tends to be high in those with pre-cancer, diabetes, heart diseases, Alzheimer’s disease and joint diseases. You can get it tested with the Inflammation marker test available in our clinic.
Alzheimer’s disease is expected to rise in Singapore’s aging population. In my opinion, it is one of the worst diseases as it affects the quality of life not only the patient but also caregivers and the entire family. Prevention is possible with herbs such as Phyllanthus emblica ( as in Phytolec), good sleep, low refined carbo and sugar diet, and an active and happy life. There is also an important role of hormones in the development of AD. This is why it occurs mainly in the elderly, where depletion of hormones started with the onset of menopause or andropause.
Khanna, S., Das, A., Spieldenner, J., Rink, C., & Roy, S. (2015). Supplementation of a Standardized Extract from Phyllanthus emblica Improves Cardiovascular Risk Factors and Platelet Aggregation in Overweight/Class-1 Obese Adults. Journal of Medicinal Food, 18(4), 415–420.
Uddin M, S, Mamun A, A, Hossain M, S, Akter F, Iqbal M, A, Asaduzzaman M, Exploring the Effect of <b><i>Phyllanthus emblica</i></b> L. on Cognitive Performance, Brain Antioxidant Markers and Acetylcholinesterase Activity in Rats: Promising Natural Gift for the Mitigation of Alzheimer’s Disease. Ann Neurosci 2016;23:218-229